Review of innovative medicines and medical technologies

"The review has explored the question of accelerated access through four workstreams spanning the development pathway and a fifth focussing on patient engagement in all parts of the pathway. Each workstream has looked across issues concerning drugs, devices, diagnostics and digital health products."

Accelerated access review: Interim report: Review of innovative medicines and medical technologies, supported by Wellcome Trust
October 2015

Read more here.

Insights on earlier adoption of medical innovations

"An international review of emerging and effective practice in improving access to medicines and medical technologies."

Insights on earlier adoption of medical innovations
S Wooding, G Cochrane, J Taylor, A Kamenetzky, S Sousa, S Parks
RAND Europe
July 2015

Read more here.

Medicines optimisation: helping patients to make the most of medicines

"Medicines optimisation is about ensuring that the right patients get the right choice of medicine, at the right time."

Medicines optimisation: helping patients to make the most of medicines
Royal Pharmaceutical Society
May 2013

Read more here.

Providing community-based health practitioners with timely and accurate discharge medicines information

"The Medicines Information Transfer Fax (MITF) is an effective approach for the timely delivery of accurate discharge medicines information to community-based practitioners responsible for the patient's ongoing care."

Providing community-based health practitioners with timely and accurate discharge medicines information
AV Gilbert, B Patel, M Morrow, D Williams, MS Roberts, AL Gilbert
BMC Health Services Research, 2012, 12:453

Read more here.

Use of NICE appraised medicines in the NHS in England

"As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England."

Use of NICE appraised medicines in the NHS in England – 2010 and 2011, experimental statistics
The Information Centre for Health and Social Care
October 2012

Access relevant documents here.

Keeping patients safe when they transfer between care providers

"Improving the transfer of information about medicines across all care settings should help to reduce incidents of avoidable harm to patients, improving patient safety and contributing to a reduction in avoidable medicines related admissions and readmissions to hospital."

Keeping patients safe when they transfer between care providers - getting the medicines right
Royal Pharmaceutical Society
June 2012

Read more here.

Keeping patients safe when they transfer between care providers

"This guidance gives health and social care professionals a common framework and clear expectations concerning good practice around the transfer of information about medicines."

Keeping patients safe when they transfer between care providers - getting the medicines right: Part 1
Royal Pharmaceutical Society
June 2011

Read more here.

Department of Health consultation on value-based system of pricing medicines

"The Department of Health is consulting on proposals for a new value-based system of pricing medicines which aims to give NHS patients better access to effective and innovative branded medicines. The consultation document sets out the principles that would underpin the move to value-based pricing, outlines how the new system could work across the UK and seeks views on a number of key issues."


A new value-based approach to the pricing of branded medicines - a consultation
Department of Health
December 2010

Read more here.

All responses to this public consultation must be received by 17 March 2011.